NFKB1 and prostate cancer: Accumulating evidence indicates that NF-κB/p65 nuclear translocation is one of the key regulators of EMT in breast cancer and pancreatic ductal adenocarcinoma [16, 17] and that another is β-catenin in colorectal and prostate cancer [18, 19].